Most recently reported pay: $7M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
Novocure Reports Patient Data Exposure in Cybersecurity Incident
Sep 7, 2026https://www.zacks.com/stock/news/2986010/novocure-reports-patient-data-exposure-in-cybersecurity-incident?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2986010sentiment -0.50
McKesson Q1 Earnings Call Highlights
Aug 8, 2026https://www.marketbeat.com/instant-alerts/mckesson-q1-earnings-call-highlights-2026-08-08/sentiment +0.90
MCK Stock Up as Q1 Earnings Beat on Specialty Growth, Guidance Raised
Aug 6, 2026https://www.zacks.com/stock/news/2970183/mck-stock-up-as-q1-earnings-beat-on-specialty-growth-guidance-raised?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2970183sentiment +0.80
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Aug 2, 2026https://www.fool.com/coverage/better-buy/2026/08/02/abbott-laboratories-vs-eli-lilly-which-healthcare-stock-is-a-better-buy-in-2026/sentiment +0.00
Here's Why McKesson (MCK) Fell More Than Broader Market
Jul 22, 2026https://www.zacks.com/stock/news/2958626/here-s-why-mckesson-mck-fell-more-than-broader-market?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6v1-2958626sentiment +0.60
Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry
Jul 14, 2026https://www.zacks.com/stock/news/2952803/zacks-industry-outlook-mckesson-cardinal-west-pharmaceutical-align-and-henry?cid=CS-STOCKNEWSAPI-FT-press_releases-2952803sentiment +0.80
